Zeidner, J. F., Foster, M. C., Blackford, A. L., Litzow, M. R., Morris, L. E., Strickland, S. A., . . . Karp, J. E. (2015). Randomized multicenter phase II study of flavopiridol (alvocidib), cytarabine, and mitoxantrone (FLAM) versus cytarabine/daunorubicin (7+3) in newly diagnosed acute myeloid leukemia. Haematologica.
Citação norma ChicagoZeidner, Joshua F., et al. "Randomized Multicenter Phase II Study of Flavopiridol (alvocidib), Cytarabine, and Mitoxantrone (FLAM) Versus Cytarabine/daunorubicin (7+3) in Newly Diagnosed Acute Myeloid Leukemia." Haematologica 2015.
ציטוט MLAZeidner, Joshua F., et al. "Randomized Multicenter Phase II Study of Flavopiridol (alvocidib), Cytarabine, and Mitoxantrone (FLAM) Versus Cytarabine/daunorubicin (7+3) in Newly Diagnosed Acute Myeloid Leukemia." Haematologica 2015.